182 related articles for article (PubMed ID: 30157705)
1. ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability.
Lee WH; Carey LM; Li LL; Xu Z; Lai YY; Courtney MJ; Hohmann AG
Mol Pain; 2018; 14():1744806918801224. PubMed ID: 30157705
[TBL] [Abstract][Full Text] [Related]
2. Disruption of nNOS-NOS1AP protein-protein interactions suppresses neuropathic pain in mice.
Lee WH; Li LL; Chawla A; Hudmon A; Lai YY; Courtney MJ; Hohmann AG
Pain; 2018 May; 159(5):849-863. PubMed ID: 29319606
[TBL] [Abstract][Full Text] [Related]
3. Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats.
Carey LM; Lee WH; Gutierrez T; Kulkarni PM; Thakur GA; Lai YY; Hohmann AG
Neuroscience; 2017 May; 349():303-317. PubMed ID: 28285942
[TBL] [Abstract][Full Text] [Related]
4. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
Slivicki RA; Xu Z; Mali SS; Hohmann AG
Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
[TBL] [Abstract][Full Text] [Related]
5. Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics.
Lee WH; Xu Z; Ashpole NM; Hudmon A; Kulkarni PM; Thakur GA; Lai YY; Hohmann AG
Neuropharmacology; 2015 Oct; 97():464-75. PubMed ID: 26071110
[TBL] [Abstract][Full Text] [Related]
6. PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model.
Sun Z; Meng P; Su C; Ji S; Gao Y; Wang H; Tian J; Li C
Toxicol Appl Pharmacol; 2021 Oct; 429():115698. PubMed ID: 34428447
[TBL] [Abstract][Full Text] [Related]
7. The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death.
Li LL; Ginet V; Liu X; Vergun O; Tuittila M; Mathieu M; Bonny C; Puyal J; Truttmann AC; Courtney MJ
J Neurosci; 2013 May; 33(19):8185-201. PubMed ID: 23658158
[TBL] [Abstract][Full Text] [Related]
8. Genetic knockout and pharmacologic inhibition of neuronal nitric oxide synthase attenuate nerve injury-induced mechanical hypersensitivity in mice.
Guan Y; Yaster M; Raja SN; Tao YX
Mol Pain; 2007 Oct; 3():29. PubMed ID: 17922909
[TBL] [Abstract][Full Text] [Related]
9. Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models.
Li LL; Melero-Fernandez de Mera RM; Chen J; Ba W; Kasri NN; Zhang M; Courtney MJ
J Neurosci; 2015 May; 35(19):7349-64. PubMed ID: 25972165
[TBL] [Abstract][Full Text] [Related]
10. A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABA
Li J; Zhang L; Xu C; Shen YY; Lin YH; Zhang Y; Wu HY; Chang L; Zhang YD; Chen R; Zhang ZP; Luo CX; Li F; Zhu DY
Theranostics; 2021; 11(12):5970-5985. PubMed ID: 33897893
[TBL] [Abstract][Full Text] [Related]
11. A Compound Mitigates Cancer Pain and Chemotherapy-Induced Neuropathic Pain by Dually Targeting nNOS-PSD-95 Interaction and GABA
Wei W; Liu W; Du S; Govindarajalu G; Irungu A; Bekker A; Tao YX
Neurotherapeutics; 2021 Oct; 18(4):2436-2448. PubMed ID: 34796458
[TBL] [Abstract][Full Text] [Related]
12. Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents.
Florio SK; Loh C; Huang SM; Iwamaye AE; Kitto KF; Fowler KW; Treiberg JA; Hayflick JS; Walker JM; Fairbanks CA; Lai Y
Br J Pharmacol; 2009 Sep; 158(2):494-506. PubMed ID: 19732061
[TBL] [Abstract][Full Text] [Related]
13. A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord.
Kunori S; Matsumura S; Okuda-Ashitaka E; Katano T; Audoly LP; Urade Y; Ito S
Glia; 2011 Feb; 59(2):208-18. PubMed ID: 21125641
[TBL] [Abstract][Full Text] [Related]
14. Endogenous nitric oxide inhibits spinal NMDA receptor activity and pain hypersensitivity induced by nerve injury.
Chen SR; Jin XG; Pan HL
Neuropharmacology; 2017 Oct; 125():156-165. PubMed ID: 28754372
[TBL] [Abstract][Full Text] [Related]
15. Hyperbaric oxygen produces a nitric oxide synthase-regulated anti-allodynic effect in rats with paclitaxel-induced neuropathic pain.
Zhang Y; Brewer AL; Nelson JT; Smith PT; Shirachi DY; Quock RM
Brain Res; 2019 May; 1711():41-47. PubMed ID: 30629945
[TBL] [Abstract][Full Text] [Related]
16. Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant-induced persistent pain.
Chu YC; Guan Y; Skinner J; Raja SN; Johns RA; Tao YX
Pain; 2005 Dec; 119(1-3):113-123. PubMed ID: 16297560
[TBL] [Abstract][Full Text] [Related]
17. nNOS-PSD95 interactions activate the PKC-ε isoform leading to increased GluN1 phosphorylation and the development of neuropathic mechanical allodynia in mice.
Choi SR; Han HJ; Beitz AJ; Lee JH
Neurosci Lett; 2019 Jun; 703():156-161. PubMed ID: 30926374
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthase 1 adaptor protein, a protein implicated in schizophrenia, controls radial migration of cortical neurons.
Carrel D; Hernandez K; Kwon M; Mau C; Trivedi MP; Brzustowicz LM; Firestein BL
Biol Psychiatry; 2015 Jun; 77(11):969-78. PubMed ID: 25542305
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal overexpression of NOS1AP promotes endophenotypes related to mental disorders.
Freudenberg F; Candemir E; Chen X; Li LL; Esen-Sehir D; Schenk N; Kinoshita M; Grünewald L; Frerichs V; Fattakhov N; Manchen J; Bikas S; Kumar A; OLeary A; Slattery DA; von Engelhardt J; Courtney MJ; Reif A
EBioMedicine; 2021 Sep; 71():103565. PubMed ID: 34455393
[TBL] [Abstract][Full Text] [Related]
20. Disrupting the nNOS/NOS1AP interaction in the medial prefrontal cortex impairs social recognition and spatial working memory in mice.
Candemir E; Fattakhov N; Leary AO; Slattery DA; Courtney MJ; Reif A; Freudenberg F
Eur Neuropsychopharmacol; 2023 Feb; 67():66-79. PubMed ID: 36513018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
